Heather Neville

Heather Neville, MSc | Medical Writer — Sunny Pharma®
Heather Neville, MSc — Senior Medical Writer, Sunny Pharma®
MSc · Medical Writer
Senior Medical Writer

Heather Neville

MSc Medical Writing · BSc Pharmacology (Hons)

“Translating the complex language of clinical science into information that empowers patients to make confident, informed decisions about their health.”

14+
Years Experience
60+
Published Works
12
Peer-Reviewed Journals
4
Continents Published

Clinical Voice. Patient-Centered Writing.

Heather Neville is a Senior Medical Writer with over 14 years of experience translating complex pharmaceutical and clinical science into authoritative, accessible content for patients, caregivers, and healthcare professionals. Her work spans HIV antiretroviral therapy, PrEP education, Hepatitis C treatment pathways, and infectious disease pharmacology.

Holding a Master of Science in Medical Writing from the University of the Arts London and an Honours Bachelor of Science in Pharmacology from the University of Edinburgh, Heather brings both scientific rigor and communicative clarity to every piece she authors. She began her career as a medical communications specialist at a London-based pharmaceutical agency before transitioning to independent contributions for clinical journals and digital health platforms across North America and Europe.

Heather’s writing philosophy centers on the conviction that every patient — regardless of literacy level or medical background — deserves to understand their treatment. This commitment has shaped her work on HIV stigma reduction campaigns funded by the Canadian AIDS Society and in patient education modules adopted by HIV clinics across British Columbia, Ontario, and California.

The greatest privilege of medical writing is standing at the intersection of science and humanity — turning data from clinical trials into sentences that give a patient hope, clarity, and the confidence to ask the right questions.

— Heather Neville, MSc

Published Work & Journal Contributions

Heather’s written contributions have appeared in peer-reviewed journals, clinical reviews, and patient-facing medical platforms across North America, Europe, Asia-Pacific, and Sub-Saharan Africa. A selection of her published and contributed works is listed below.

  • 📄
    Adherence Outcomes with Single-Tablet Bictegravir/TAF/FTC Regimens in Treatment-Naive Adults: A Real-World Review
    Journal of Acquired Immune Deficiency Syndromes (JAIDS) · 2023 · Vol. 94, No. 2
  • 📄
    Integrase Strand Transfer Inhibitors: Mechanisms, Resistance Pathways, and Patient Communication Strategies
    Antiviral Therapy · 2022 · International Journal of the International Society of Antiviral Research
  • 📄
    PrEP Uptake Barriers Among Cisgender Women in Urban Canadian Centres: A Narrative Review
    Canadian Journal of Infectious Diseases and Medical Microbiology · 2022
  • 📄
    Plain Language Summaries for HIV Treatment Guidelines: A Readability Audit of DHHS, EACS, and WHO Documents
    Patient Education and Counseling · 2021 · Elsevier
  • 📄
    Dolutegravir-Based ART in Resource-Limited Settings: Patient-Centered Communication and Adherence Support
    The Lancet HIV · Correspondence · 2021
  • 📄
    Hepatitis C Cure Rates in Indigenous Communities: Communicating SVR12 Data Without Oversimplification
    Journal of Viral Hepatitis · 2020 · Wiley
  • 📄
    Patient-Reported Outcomes in HIV Long-Term Non-Progressors: A Medical Writing Perspective on Data Communication
    AIDS and Behavior · 2020 · Springer
  • 📄
    Generic Antiretrovirals in Low- and Middle-Income Countries: An Evidence Review for Patient Advocacy Groups
    Global Health: Science and Practice · 2019 · Johns Hopkins University Press

Editorial Process & Conflict of Interest

All content authored by Heather Neville for Sunny Pharma® is produced in strict accordance with the site’s Editorial Policy. Each article is independently researched from primary clinical sources including FDA-approved prescribing information, DHHS guidelines, and peer-reviewed literature indexed on PubMed.

Heather has no financial relationships with antiretroviral or antiviral pharmaceutical manufacturers. Her compensation from Sunny Pharma® is a flat editorial fee, entirely independent of commercial outcomes. She discloses this policy in accordance with ICMJE guidelines for medical writers.

Last credentials verified: January 2025  |  Content reviewed by: Wendy Chamberlain, Editor-in-Chief